AzTrials
AzTrials

Amputation, SurgicalDEVSYMENCT06448260

Outcome of a Cohort of Patients Fitted With a SYME Type Prosthesis in the Context of a Hindfoot Amputation With Distal Support

An observational study of Amputation, Surgical and Walking, Difficulty, run by Institut Robert Merle d'aubigné at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to see outcome of patients with syme prothesis in order to comment the handfoot amputation. Read more about this study

Who is it for?
Any age
Conditions the study is for
Amputation, Surgical, Walking, Difficulty
What is being tested?
Questionnary
How many people
94 participants
Where
1 siteFrance
Study dates
20 May 2024to 30 Sep 2024
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patient treated at the institut Rober Merle d'Aubigné

Who may be able to join

  • Syme or Pirogoff or ATCT or arthrodesized Chopart type amputation
  • Age > 18 years old,
  • First fitting or renewal of Syme type prosthesis delivered to IRMA between January 2008 and December 2018

Who cannot join

  • Refusal documented in the file that the data be used for scientific purposes,
  • Congenital etiology of the condition.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Institut Robert Merle d'Aubigné

    Valenton

Other trials in France

About this study

The purpose of this study is to see outcome of patients with syme prothesis in order to comment the handfoot amputation.

Being tested
Questionnary
Keywords
Amputation, Prothesis, Outcome
Medical subject headings
Mobility Limitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaryOther

    Data from theses patients will be collected in our personnal data base with ask of consent according to the law Then each patient alive will have questionnary to answer by phone or during a visit.

Study groups in NCT06448260
Study groupRoleWhat they receive
Patient with ATCTPatient with tibiocalcaneal arthrodesis with talectomy amputation
Receives: Other: Questionnary

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The possibility of walking without a prosthesis

    Yes / No

    Measured: Immediatly after inclusion

  2. Walking perimeter with prosthesis

    In meters

    Measured: Immediatly after inclusion

  3. Number of re-amputation since first amputation

    Measured: Immediatly after inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jun 2024
  2. Study start20 May 2024
  3. Primary completion31 Jul 2024
  4. Study completion30 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
94 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06448260
Sponsor's protocol ID
2024-A00393-44
Acronym
DEVSYME
Status last verified
Oct 2024
First submitted
1 Jun 2024
Last updated
16 Apr 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Braaksma R, Dijkstra PU, Geertzen JHB. Syme Amputation: A Systematic Review. Foot Ankle Int. 2018 Mar;39(3):284-291. doi: 10.1177/1071100717745313. Epub 2018 Jan 10.

    PubMed 29320640
  • Dillon MP, Quigley M, Fatone S. Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources. Syst Rev. 2017 Mar 14;6(1):54. doi: 10.1186/s13643-017-0433-7.

    PubMed 28288686
  • van der Wal GE, Dijkstra PU, Geertzen JHB. Lisfranc and Chopart amputation: A systematic review. Medicine (Baltimore). 2023 Mar 10;102(10):e33188. doi: 10.1097/MD.0000000000033188.

    PubMed 36897730
  • Spoden M, Nimptsch U, Mansky T. Amputation rates of the lower limb by amputation level - observational study using German national hospital discharge data from 2005 to 2015. BMC Health Serv Res. 2019 Jan 6;19(1):8. doi: 10.1186/s12913-018-3759-5.

    PubMed 30612550

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation, Surgical and Walking, Difficulty, run by Institut Robert Merle d'aubigné at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The possibility of walking without a prosthesis (time frame: Immediatly after inclusion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06448260, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in